%0 Journal Article
%T The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
%A Buster EH
%A Baak BC
%A Bakker CM
%A Beuers UH
%A Brouwer JT
%A Drenth JP
%A van Erpecum KJ
%A van Hoek B
%A Honkoop P
%A Kerbert-Dreteler MJ
%A Koek GH
%A van Nieuwkerk KM
%A van Soest H
%A van der Spek BW
%A Tan AC
%A Vrolijk JM
%A Janssen HL
%J Neth J Med
%V 70
%N 8
%D Oct 2012
%M 23065990
%F 1.105
%R 
%X In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance.